Loss of TIMP3 enhances interstitial nephritis and fibrosis.
about
Diverse functions of matrix metalloproteinases during fibrosisTubulointerstitial injury and the progression of chronic kidney diseaseMatrix metalloproteinases in kidney homeostasis and diseasesDiabetic kidney disease: from physiology to therapeuticsCharacterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cellsDown-regulation of TIMP3 leads to increase in TACE expression and TNFα production by placental trophoblast cells.ADAM-17: the enzyme that does it all.A disintegrin and metalloenzyme (ADAM) 17 activation is regulated by α5β1 integrin in kidney mesangial cells.Loss of Timp3 gene leads to abdominal aortic aneurysm formation in response to angiotensin IIA glimpse of matrix metalloproteinases in diabetic nephropathy.Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).Absence of nicotinic acetylcholine receptor α7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model.Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.The history of matrix metalloproteinases: milestones, myths, and misperceptions.Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling PathwayADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice.Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease.Inhibition of the TGFβ signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis.Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay.Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells.Human recombinant ACE2 reduces the progression of diabetic nephropathy.Loss of TIMP3 selectively exacerbates diabetic nephropathy.Proteomic and metabolomic characterization of streptozotocin-induced diabetic nephropathy in TIMP3-deficient mice.Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy.TIMP3 deficiency exacerbates iron-overload mediated cardiomyopathy and liver disease.Skeletal muscle TLR4 and TACE are associated with body fat percentage in older adults.Resolution of organ fibrosis.ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis.Delayed Treatment with Plasminogen Activator Inhibitor-1 Decoys Reduces Tubulointerstitial FibrosisTargeting enhancer of zeste homolog 2 protects against acute kidney injury
P2860
Q26825368-B15129AA-DAB8-4049-BF4F-E0B1975678B1Q26852862-F3B64653-A8DB-4A6E-A3C5-B5C798A7E9F9Q27004621-3FC84B54-20F5-4197-AD73-17C42207FABFQ27021392-C90780EF-451A-452B-9145-10889E937C85Q28538745-329D3C77-DC91-4E99-A22B-75D29C7CB034Q33596885-CF452F36-2F24-4922-A7AF-630FE40F4FC9Q33737421-DFDDFA26-6558-4D6E-A20E-EE0CD1759FD3Q34193829-B3BB8230-40DE-48BF-B4DF-D9B160A22EBFQ34311153-457568BF-1A35-4FDE-B311-340D6A051F67Q34796034-5C9FB6B3-8983-4F2F-B636-332ECA227099Q35102315-F3EDBB5E-23F4-4FC5-8DAB-E4A8C27F949EQ35194509-4F5F846F-8D69-4C70-9954-BA153E6CD091Q35879006-80D91004-B135-4CD8-9E57-9133EE181C0FQ35903082-01592D94-99D3-43DA-8A83-65E86E865EC0Q35917508-61EBF116-386F-4CD9-A7BC-859E4107EAE9Q36312509-C1BC1C0D-B21B-47EA-8629-B586F0DE8E42Q36763871-6921F7DA-5AA9-4307-9BDF-E8AE607E454FQ37018721-C95A8D25-EF31-4D52-9B9D-59A07AAFC03DQ37093660-2B1D3DB4-6C6C-44AB-84B5-FD7F35B63A0CQ37568489-C50E2420-F61E-4E12-A193-0EBAD173F545Q37734788-8D523ECB-6CE6-4AEE-B16A-5ECE191A4AD4Q37895982-1903DB83-514A-448A-B3BA-6614F7763C1DQ38942962-53AD2C22-FE97-4843-AF2B-C67F1E3422ACQ39135585-15E121E1-96CB-4CD0-AD7F-4C85C3E73223Q39196199-9DA039E6-2577-4F44-91B7-5340F4284E9DQ39600283-E0EF0763-DFB4-4A24-9D6A-E19D9AF5AC36Q41786103-14E99008-1284-4257-894D-493BCBF13EE7Q42402000-86C0A5F5-475B-41CD-896E-47DBD651DF45Q47406292-4DC26498-5D5D-4B49-9362-190342AE4BE3Q48300010-C5A9D166-5B6D-43BA-9D5A-37581DDF1936Q49663340-5DC8DF3A-7074-4539-975F-64E11A8AC710Q51287207-2FCE7FD8-E655-4E94-A606-087CCEA50508Q52687459-5E429877-AA4C-4C03-A932-046EA345CAC7Q54343045-2EA6561E-BD59-4DB0-8070-4EEAE9DE2D3EQ57718662-F20D348F-18F1-46E2-AE0F-E6204B33D695Q57809701-A403023F-874D-4A97-8EAF-7DC551B07FBD
P2860
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
@en
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
@nl
type
label
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
@en
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
@nl
prefLabel
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
@en
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
@nl
P2093
P2860
P356
P1476
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
@en
P2093
Ahmed Awad
Andrew M Herzenberg
Gavin Y Oudit
James W Scholey
Nobuyo Maeda
Vijay Kandalam
Xiuhua Wang
Xiuhua Ziou
Zamaneh Kassiri
P2860
P304
P356
10.1681/ASN.2008050492
P577
2009-04-30T00:00:00Z